Close

Galena Biopharma (GALE) Announces Launch of Abstral Tabs in U.S.

October 3, 2013 7:07 AM EDT Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced the official product launch of AbstralĀ® (fentanyl) Sublingual Tablets in the United States. Abstral is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login